ATE92633T1 - Verfahren zur erhoehung der spezifizitaet in kompetitiven immuntests. - Google Patents

Verfahren zur erhoehung der spezifizitaet in kompetitiven immuntests.

Info

Publication number
ATE92633T1
ATE92633T1 AT89106445T AT89106445T ATE92633T1 AT E92633 T1 ATE92633 T1 AT E92633T1 AT 89106445 T AT89106445 T AT 89106445T AT 89106445 T AT89106445 T AT 89106445T AT E92633 T1 ATE92633 T1 AT E92633T1
Authority
AT
Austria
Prior art keywords
immunotesting
competitive
methods
increase specificity
improved
Prior art date
Application number
AT89106445T
Other languages
English (en)
Inventor
Richard H Decker
John A Weare
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22713085&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE92633(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE92633T1 publication Critical patent/ATE92633T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/557—Immunoassay; Biospecific binding assay; Materials therefor using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5762—Hepatitis B core antigen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
AT89106445T 1988-05-11 1989-04-11 Verfahren zur erhoehung der spezifizitaet in kompetitiven immuntests. ATE92633T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19330788A 1988-05-11 1988-05-11
EP89106445A EP0341439B1 (de) 1988-05-11 1989-04-11 Verfahren zur Erhöhung der Spezifizität in kompetitiven Immuntests

Publications (1)

Publication Number Publication Date
ATE92633T1 true ATE92633T1 (de) 1993-08-15

Family

ID=22713085

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89106445T ATE92633T1 (de) 1988-05-11 1989-04-11 Verfahren zur erhoehung der spezifizitaet in kompetitiven immuntests.

Country Status (9)

Country Link
US (2) US5681695A (de)
EP (1) EP0341439B1 (de)
JP (1) JP2945025B2 (de)
KR (1) KR900018679A (de)
AT (1) ATE92633T1 (de)
AU (1) AU613187B2 (de)
CA (1) CA1335706C (de)
DE (1) DE68907996T2 (de)
ES (1) ES2059601T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5817525A (en) * 1995-05-19 1998-10-06 Chiron Diagnostics Corporation Stable protein solutions for diagnostics and method of making and using the same
DE19649390A1 (de) 1996-11-29 1998-06-04 Boehringer Mannheim Gmbh Antigenspezifischer IgG-Nachweis
US6153392A (en) * 1997-07-30 2000-11-28 Bionova Corporation Devices and methods comprising an HBcAg from hepatitis B virus
DK1021719T3 (da) 1997-09-22 2007-06-18 Novartis Vaccines & Diagnostic Fremgangsmåde til påvisning af antistoffer i en pröve
WO1999015901A1 (en) * 1997-09-22 1999-04-01 Chiron Corporation Buffers for stabilizing antigens
JP2002512370A (ja) * 1998-04-17 2002-04-23 イノジェネティックス・ナムローゼ・フェンノートシャップ 還元剤を用いる改良された免疫診断アッセイ
IL151035A0 (en) 2000-02-09 2003-04-10 Daiichi Seiyaku Co Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
US20020064881A1 (en) * 2000-11-30 2002-05-30 Devlin William Jackson Method for automatically storing and reprocessing patient specimen's in an automatic clinical analyzer
US6723851B2 (en) 2001-10-31 2004-04-20 Quest Diagnostics Investment Incorporated Chemiluminescent compounds and use thereof
US7674632B1 (en) 2001-12-10 2010-03-09 Zeus Scientific, Inc Method and composition for homogeneous multiplexed microparticle-based assay
CN1997895A (zh) * 2004-05-19 2007-07-11 株式会社先端生命科学研究所 乙型肝炎病毒的检测方法
US20060134647A1 (en) * 2004-12-17 2006-06-22 Sylwia Karwowska Method for elimination of false reactivities in immunoassay for Hepatitis A virus
US8112229B2 (en) * 2007-05-31 2012-02-07 Abbott Laboratories Method for determining the order of execution of assays of a sample in a laboratory automation system
JP5163883B2 (ja) * 2008-05-30 2013-03-13 東ソー株式会社 Ｂ型肝炎ウイルスコア抗原又はそれに対する抗体の測定方法
JP7209498B2 (ja) * 2017-09-15 2023-01-20 富士レビオ株式会社 Ｂ型肝炎ウイルスコア抗体の免疫測定方法
CN113777312B (zh) * 2021-09-03 2024-02-02 普十生物科技(北京)有限公司 乙肝抗体片段的制备方法、乙肝抗体片段、试剂盒及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1100037A (en) * 1977-03-11 1981-04-28 Chung-Mei Ling Hb.sub.c ag coated on solid phase
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
US4234564A (en) * 1977-12-19 1980-11-18 Merck & Co., Inc. Hepatitis B core antigen composition
AU527489B2 (en) * 1978-03-20 1983-03-10 Abbott Laboratories Sugar coated reagents for solid phase immunoassay
US4241175A (en) * 1978-12-18 1980-12-23 Merck & Co., Inc. Assay for hepatitis B core antibody
US4310508A (en) * 1979-06-19 1982-01-12 Siber George Diagnostic test and reagent therefor
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
JPS60256057A (ja) * 1984-06-01 1985-12-17 Dai Ichi Pure Chem Co Ltd 免疫学的測定法
US4683136A (en) * 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants
WO1987003690A1 (en) * 1985-12-10 1987-06-18 Murex Corporation Particle-bound binding component immunoassay

Also Published As

Publication number Publication date
EP0341439B1 (de) 1993-08-04
US6150113A (en) 2000-11-21
US5681695A (en) 1997-10-28
ES2059601T3 (es) 1994-11-16
JPH01321365A (ja) 1989-12-27
JP2945025B2 (ja) 1999-09-06
EP0341439A1 (de) 1989-11-15
CA1335706C (en) 1995-05-30
DE68907996D1 (de) 1993-09-09
AU3464189A (en) 1989-11-16
AU613187B2 (en) 1991-07-25
KR900018679A (ko) 1990-12-22
DE68907996T2 (de) 1994-01-05

Similar Documents

Publication Publication Date Title
ATE92633T1 (de) Verfahren zur erhoehung der spezifizitaet in kompetitiven immuntests.
DE3685930D1 (de) Verfahren zur bestimmung von mimitopen.
DE68909345D1 (de) Verfahren und Kompositionen zur Erzeugung verstärkter Chemilumineszenz von 1,2-Dioxetanen.
IL78782A0 (en) Method and test kit for competitive enzyme-linked immunosorbent assay for the detection of antibodies
ZA855031B (en) Assay for simultaneous detection of antigen and antibody in given serum
IT8048878A0 (it) Procedimento per determinare un complesso di antigene od anticorpo e corredo di reagenti per esso
DK362287D0 (da) Method for rapid and sensitive detection of hiv-1 antibodies
DE3776525D1 (de) Immunochemisches verfahren zur bestimmung von stabilem glykosiliertem haemoglobin.
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
DK610587A (da) Analysemetode og -saet for antistof til hepatitis b-kerneantigen
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
FI881355A7 (fi) Määritysmenetelmä hepatiittiantigeenien ja AIDS-vasta-aineiden toteamiseksi.
DE68914252D1 (de) Verfahren zur Bestimmung eines Antigens.
DE69231719D1 (de) Diagnostisches Reagenz für Hepatitis C
FR2325934A1 (fr) Methode de detection de la presence d'un antigene associe a l'hepatite
ATE79475T1 (de) Verfahren zur bestimmung von immunoglobulin-aprotease.
JPS5667757A (en) Method of detecting and determining hapten and antigen
DE3874741D1 (de) Immunassay-verfahren.
ATE174688T1 (de) Verfahren zur bestimmung von antigenen oder antikörpern in gegenwart eines immunkomplexes
NO175024C (no) Agglutineringsreagens og dets anvendelse for detektering av et antigen, antistoffer eller andre analytter, samt prövesett omfattende reagensen
ATE22997T1 (de) Verfahren zur immunologischen bestimmung, unter verwendung zweier antikoerper, wobei der zweite antikoerper durch affinitaetschromatographie gereinigt ist, und traeger dafuer.
ATE107031T1 (de) Verfahren zur bestimmung eines liganden.
ATE42002T1 (de) Verfahren zur immunochemischen bestimmung von hepatitis-b-core-antigenen.
ATE54758T1 (de) Verfahren zur bestimmung der antikoerper vom herpes-simplex-virus.
NO870461D0 (no) Reagens for paavisning av antistoff mot virusantigener.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time